Overview

Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.
Phase:
Phase 3
Details
Lead Sponsor:
Medivir